Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In this era of precision and personalized medicine there is an increasing need to develop a POCT with molecular genetic testing that produces a risk assessment based on a comprehensive profile for targeted therapy
Apart from the influence of BDNF on development of neuronal subpopulations representing different neurotransmitter systems, results of recent studies have demonstrated a stimulatory effect of the serotoninergic system on BDNF/TrkB receptor complex-initiated neurogenesis (Gould 1999)
Carboxylic acids including several nonsteroidal antiinflammatory agents are conjugated mainly by UGT1A3, UGT1A4, UGT1A9, and UGT2B7 (Tukey & Strassburg, 2000)
Molecular targeted therapy for anticancer treatment
US$ 26.25
US$ 27.00
US$ 21.98
US$ 21.23
US$ 27.04
US$ 22.38
US$ 20.18
US$ 20.76
US$ 26.98
US$ 24.59
US$ 29.55
